| 摘要 |
<p>The present invention relates to the use of an agonist of the melanin-concentrating hormone receptor-1, in particular melanin-concentrating hormone, or a derivative thereof, or an analogue thereof at the manufacture of a pharmaceutical preparation for the treatment of osteoporosis in mammalians by providing an agonistic effect on the melanin-concentrating hormone receptor-1, as well as a method for treating or preventing osteoporosis.</p> |
